Skip to main content
. 2018 Aug 30;10(9):294. doi: 10.3390/cancers10090294

Figure 2.

Figure 2

Diagnostic accuracy of plasma-circulating miRNA-130a conducted by ROC analysis with AUC calculation. (A) a test for distinguishing cachectic patients (loss of at least 5% of body weight) from other patients; (B) a test for distinguishing cachectic patients (loss of at least 5% of body weight) with subsequent high TNF-α plasma concentration from other patients.